Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Raniwel 50
Raniwel 50 (Ranitidine Injection 50 mg) is a fast-acting H2 receptor blocker used for the treatment and prevention of acid-related gastrointestinal conditions.
Uses of Raniwel 50
Treatment of peptic ulcers and gastroesophageal reflux disease (GERD)
Management of Zollinger-Ellison syndrome (excess stomach acid production)
Prevention of stress ulcers in critically ill patients
Control of acid reflux in patients unable to take oral medications
Benefits of Raniwel 50
Rapid reduction of stomach acid production
Provides relief from acid-related pain and discomfort
Can be administered via IV or IM for immediate effect
Prevents complications from acid reflux and ulcers
Mechanism of Action of Raniwel 50
Ranitidine blocks H2 receptors in the stomach, reducing acid secretion and preventing gastric irritation.